Sherlock Biosciences Launches with $35M, Aiming to Improve Diagnostic Testing

Sherlock Biosciences Launches with $35M, Aiming to Improve Diagnostic Testing »

22 Mar, 2019
CompaniesNews
  Cambridge-based engineering biology company Sherlock Biosciences this week announced its launch with $35 million in financing — and its eyes are on CRISPR gene-editing tech. Sherlock Biosciences aims to make diagnostic testing better, faster and more affordable. The company uses engineering biology tools, including CRISPR, to create a new generation of molecular diagnostics that rapidly…
Top 5 Reads of the Week

Top 5 Reads of the Week »

24 Jun, 2016
NewsUncategorized

In this week’s MTB Roundup: communicable cancer in clams, at home sperm tests, botched “stem-cell tourism” and more…

The 12 Technologies That Will Revolutionize Cancer Care

The 12 Technologies That Will Revolutionize Cancer Care »

27 Apr, 2016
NewsUncategorized

On the final day of the World Medical Innovation Forum, Partners Healthcare announced selections for its "Disruptive Dozen," the 12 technologies poised to revolutionize cancer care over the next decade.

Send this to a friend